Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use
Drug Saf 32(2):147-158 (2009) PMID 19236121
The antiretroviral nevirapine can cause severe hepatotoxicity when used 'off-label' for preventing mother-to-child HIV transmission (PMTCT), newborn post-exposure prophylaxis and for pre- and post-exposure prophylaxis among non-HIV-infected individuals. We describe the incidence of hepatotoxicity with short- versus long-course nevirapine-containing regimens in these groups.
DOI: 10.2165/00002018-200932020-00007
Version: za2963e q8zac q8zbd q8zca q8zda q8zef q8zf9 q8zg8